Sponsor Check › Person
Named as an officer, director or promoter on SEC Form D filings · MA · Apr 14, 2017 → Jul 27, 2020
Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:22 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET
Christopher R. Loose is listed as an executive officer and director on 5 SEC Form D filings by 3 issuers between Dec 2010 and May 2024: Progentos Therapeutics, Inc. (Watertown, MA — industry reported as "Other" — 2024; $68.6M reported sold to 39 investors), Frequency Therapeutics, Inc. (Woburn, MA — biotechnology — 2017–2020; $62M reported sold to 90 investors) and SEMPRUS BIOSCIENCES CORP (Cambridge, MA — other health care — 2010; $9M reported sold to 5 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer and director, over about 14 years. Across those companies the filings report $139.6M sold in total.
Listed alongside David Lucchino (4 shared filings), Robert Langer (4 shared filings), Marc Cohen (3 shared filings), Timothy J. Barberich (3 shared filings), Carl P. LeBel (2 shared filings) and 16 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Christopher. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — 13 court cases matching the name, 10 bankruptcy cases matching the name listed in Key records below.
What this means 23 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 5 public filings for Christopher R. Loose and found 4 differences: Bankruptcy case: Richard J. Mitrano; Christopher R. Loose appears on 1 deal that stopped filing before reaching its target; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.
Community search for Christopher R. Loose has not run yet — it is joining a line of 21,099 names; searches run around the clock at the hosts' allowed rate. Searched so far: 329 names.
Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).
Five things investors ask first. Items still in human review are counted, not shown.
13 cases: 5 dismissed, 7 closed (disposition not in docket feed), 1 judgment
791 Employee Retirement Income Security Act
890 Other Statutory Actions· Cause:
15:1692 Fair Debt Collection Act
367 Health care / pharm
367 Health care / pharm
190 Other contract actions
Real Property: Other· Cause:
28:1332 Diversity - Real Property
190 Other contract actions
890 Other statutory actions
380 Other personal property damage· Cause:
28:2410 Action affecting property on which US has lien
380 Other personal property damage
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:22 AM ET.
Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: NV (crawled Oct 23, 2026)
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Christopher R. Loose..
State securities regulators: Securities regulators searched (3,318 actions): AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002), DE DOJ Investor Protection Unit (257 actions, 1987–2026), TX State Securities Board (586 actions, 2006–2026), WA DFI (2,039 actions, 2001–2026) — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first — last crawled Oct 23, 2026, 9:57 PM ET. No machine-readable public listing today for IA, IN, KS, MI, NE, NV (see docs/state-regulators.md).
10 cases: 10 closed (disposition not in docket feed)
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:22 AM ET.
Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons cover issuers and sponsor groups — see the issuer pages under Deals
4 differences found between the filings for Christopher R. Loose (compared 5 filings on Oct 24, 2026)
United States Bankruptcy Court, D. Massachusetts docket "Richard J. Mitrano" filed Sep 6, 1996, closed Dec 18, 1996. Richard Mitrano (listed on the same filings) is listed as Debtor ("Richard J. Mitrano"). Our match estimate: 80%.
What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.
SEMPRUS BIOSCIENCES CORP (last filing Dec 22, 2010; $9,004,031 sold of $18,804,034). Each has no filing in more than two years and reported under half its target sold.
What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.
The latest filing for this offering is dated Dec 22, 2010 (first sale Dec 9, 2010). It reports $9,004,031 sold of $18,804,034 offered. No later amendment is in our index as of Oct 24, 2026.
What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.
listed as "Christopher Loose" on 2 filings (from Dec 22, 2010), and "Christopher R. Loose" on 3 filings (from Apr 14, 2017).
What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.
What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.
1 of 5 offerings reports sales commissions totalling $2,045,098; 0 report finder's fees; 0 report proceeds to related persons.
| Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it | Source |
|---|---|---|---|---|---|
| May 17, 2024 D Progentos Therapeutics, Inc. File 021-513638 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jul 27, 2020 D Frequency Therapeutics, Inc. File 021-371826 | $2,045,098 | $0 | $0 | Cowen and Company, LLC BrokerCheck CRD 7616 ↗ | EDGAR ↗ |
| Jul 23, 2019 D Frequency Therapeutics, Inc. File 021-344894 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Apr 14, 2017 D Frequency Therapeutics, Inc. File 021-284867 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Dec 22, 2010 D SEMPRUS BIOSCIENCES CORP File 021-152404 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
Every issuer that named Christopher R. Loose on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.
Raised $68.6M from 39 investors (100% of the $68.6M target) as of the latest filing. Christopher is listed as executive officer, director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $62M from 90 investors (100% of the $42.3M target) as of the latest filing. Christopher is listed as executive officer on 3 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $9M from 5 investors (48% of the $18.8M target) as of the latest filing. Christopher is listed as executive officer.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.
Robert Langer is on 48 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Christopher R. Loose. Their page shows their other deals.
Timothy J. Barberich is on 11 issuers in total — a repeat sponsor. Their page lists every one.
Marc Cohen is on 10 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Christopher R. Loose. Their page shows their other deals.
Listed on the same filings as Christopher R. Loose. Their page shows their other deals.
Listed on the same filings as Christopher R. Loose. Their page shows their other deals.
Listed on the same filings as Christopher R. Loose. Their page shows their other deals.
Listed on the same filings as Christopher R. Loose. Their page shows their other deals.
Scott Rocklage is on 18 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Christopher R. Loose. Their page shows their other deals.
Listed on the same filings as Christopher R. Loose. Their page shows their other deals.
Listed on the same filings as Christopher R. Loose. Their page shows their other deals.
Listed on the same filings as Christopher R. Loose. Their page shows their other deals.
Listed on the same filings as Christopher R. Loose. Their page shows their other deals.
Listed on the same filings as Christopher R. Loose. Their page shows their other deals.
Listed on the same filings as Christopher R. Loose. Their page shows their other deals.
Listed on the same filings as Christopher R. Loose. Their page shows their other deals.
Listed on the same filings as Christopher R. Loose. Their page shows their other deals.
Listed on the same filings as Christopher R. Loose. Their page shows their other deals.
Listed on the same filings as Christopher R. Loose. Their page shows their other deals.
A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.
None of the 3 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.
Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.
Property records are matched to companies only, never to individuals, so none are matched to Christopher R. Loose by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 3 issuers this person is listed on — nothing matched.
Websites and social links of the issuers Christopher R. Loose is listed on: none on file. No website or social profile named in Progentos Therapeutics, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #99,527 of 374,652 in line (528 issuers searched so far). One-tap searches: Look further ↓
One-tap searches on sites we do not index ourselves, with the name pre-filled (Watertown, MA). Each opens in a new tab; what you find there is not verified by PartnerFacts.
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when Christopher R. Loose appears on a new Form D, or when a court case or SEC action is matched to them. See plans →